These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 27312025)
1. Sebaceous Gland Atrophy in Psoriasis: An Explanation for Psoriatic Alopecia? Rittié L; Tejasvi T; Harms PW; Xing X; Nair RP; Gudjonsson JE; Swindell WR; Elder JT J Invest Dermatol; 2016 Sep; 136(9):1792-1800. PubMed ID: 27312025 [TBL] [Abstract][Full Text] [Related]
2. Marked Reduction of the Number and Individual Volume of Sebaceous Glands in Psoriatic Lesions. Liakou AI; Nyengaard JR; Bonovas S; Knolle J; Makrantonaki E; Zouboulis CC Dermatology; 2016; 232(4):415-24. PubMed ID: 27250651 [TBL] [Abstract][Full Text] [Related]
3. A morphometric and histologic study of the scalp in psoriasis. Paradoxical sebaceous gland atrophy and decreased hair shaft diameters without alopecia. Headington JT; Gupta AK; Goldfarb MT; Nickoloff BJ; Hamilton TA; Ellis CN; Voorhees JJ Arch Dermatol; 1989 May; 125(5):639-42. PubMed ID: 2637673 [TBL] [Abstract][Full Text] [Related]
4. Histopathologic study of scalp psoriasis: peculiar features including sebaceous gland atrophy. Werner B; Brenner FM; Böer A Am J Dermatopathol; 2008 Apr; 30(2):93-100. PubMed ID: 18360109 [TBL] [Abstract][Full Text] [Related]
5. Sebaceous gland atrophy due to seborrheic dermatitis in a patient with alopecia: A potential pitfall. Zengin S; Guthrie J; Zoumberos N; Hamza M; Shalin SC J Cutan Pathol; 2024 Jul; 51(7):513-517. PubMed ID: 38613429 [TBL] [Abstract][Full Text] [Related]
6. Sebaceous gland atrophy in seborrheic dermatitis of the scalp; a pilot study. Nagrani NS; Goldberg LJ J Cutan Pathol; 2022 Nov; 49(11):988-992. PubMed ID: 36222212 [TBL] [Abstract][Full Text] [Related]
9. Changes in the sebaceous gland in patients with male pattern hair loss (androgenic alopecia). Kure K; Isago T; Hirayama T J Cosmet Dermatol; 2015 Sep; 14(3):178-84. PubMed ID: 26147300 [TBL] [Abstract][Full Text] [Related]
10. Sebaceous gland loss and inflammation in scarring alopecia: a potential role in pathogenesis. Al-Zaid T; Vanderweil S; Zembowicz A; Lyle S J Am Acad Dermatol; 2011 Sep; 65(3):597-603. PubMed ID: 21669475 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of DGAT1 induces sebaceous gland atrophy in mouse and dog skin while overt alopecia is restricted to the mouse. Floettmann E; Lees D; Seeliger F; Jones HB Toxicol Pathol; 2015 Apr; 43(3):376-83. PubMed ID: 25112279 [TBL] [Abstract][Full Text] [Related]
12. Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin. Jiang WY; Chattedee AD; Raychaudhuri SP; Raychaudhuri SK; Farber EM Int J Dermatol; 2001 Nov; 40(11):699-703. PubMed ID: 11737436 [TBL] [Abstract][Full Text] [Related]
13. RNA-seq identifies a diminished differentiation gene signature in primary monolayer keratinocytes grown from lesional and uninvolved psoriatic skin. Swindell WR; Sarkar MK; Liang Y; Xing X; Baliwag J; Elder JT; Johnston A; Ward NL; Gudjonsson JE Sci Rep; 2017 Dec; 7(1):18045. PubMed ID: 29273799 [TBL] [Abstract][Full Text] [Related]
14. Psoriatic alopecia - fact or fiction? A clinicohistopathologic reappraisal. Silva CY; Brown KL; Kurban AK; Mahalingam M Indian J Dermatol Venereol Leprol; 2012; 78(5):611-9. PubMed ID: 22960818 [TBL] [Abstract][Full Text] [Related]
15. Derivation of marker gene signatures from human skin and their use in the interpretation of the transcriptional changes associated with dermatological disorders. Shih BB; Nirmal AJ; Headon DJ; Akbar AN; Mabbott NA; Freeman TC J Pathol; 2017 Apr; 241(5):600-613. PubMed ID: 28008606 [TBL] [Abstract][Full Text] [Related]
16. Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. Gudjonsson JE; Ding J; Johnston A; Tejasvi T; Guzman AM; Nair RP; Voorhees JJ; Abecasis GR; Elder JT J Invest Dermatol; 2010 Jul; 130(7):1829-40. PubMed ID: 20220767 [TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody. Russell CB; Rand H; Bigler J; Kerkof K; Timour M; Bautista E; Krueger JG; Salinger DH; Welcher AA; Martin DA J Immunol; 2014 Apr; 192(8):3828-36. PubMed ID: 24646743 [TBL] [Abstract][Full Text] [Related]
19. The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris. Alessandrini F; Stachowitz S; Ring J; Behrendt H J Invest Dermatol; 2001 Mar; 116(3):394-400. PubMed ID: 11231313 [TBL] [Abstract][Full Text] [Related]